Company

About

Berlin Heals Holding AG

Berlin Heals Holding AG

knesebeckstr. 59-61, zug, canton of zug, switzerland

Berlin Heals is a Start-up-Company in Berlin, Germany. We are devoted to the treatment of heart failure. We will redefine heart failure treatment with a novel device that is capable of healing the heart. Contact us at info@berlinheals.de to get in touch with us. Get more Information here: www.berlinheals.de

Medacta International

Medacta International

Strada Regina, Castel San Pietro, Ticino, CH, 6874

Medacta is an international company specializing in the design, production, and distribution of innovative orthopaedic products, as well as in the development of accompanying surgical techniques. Established in 1999 in Switzerland, Medacta is active in joint replacement, spine surgery, and sports medicine. Medacta is committed to improving the care and well-being of patients and maintains a strong focus on healthcare sustainability. Medacta's innovation, forged by close collaboration with surgeon leaders globally, began with minimally invasive surgical techniques and has evolved into personalized solutions for every patient. Through the M.O.R.E. Institute, Medacta supports surgeons with a comprehensive and tailored program dedicated to the advancement of medical education. Medacta is headquartered in Castel San Pietro, Switzerland, and operates in over 50 countries.

Novostia

Novostia

Rue la Corniche 4, Epalinges / Lausanne, 1066, CH

Novostia is a privately held medical device company developing an innovative artificial heart valve, designed for patients of any age, including children. Novostia endeavors to advance its technology to clinical trials and regulatory approvals to improve the quality of life of millions of people worldwide suffering from aortic and mitral valve disease. For more information please visite www.novostia.com

ObsEva

ObsEva

Geneve, Switzerland

Innovating Women’s Reproductive Health and Pregnancy Therapeutics ObsEva is a clinical-stage biopharmaceutical company focused on the clinical development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy. Through strategic in-licensing and disciplined drug development, ObsEva has established a late-stage clinical pipeline with development programs focused on treating endometriosis, uterine fibroids, preterm labor and improving ART outcomes.

PB&B

PB&B

Lausanne, Switzerland

PB&B is a Life Sciences company that specializes in patented injectable technology for remodeling soft tissues of the face and body.

Spineart

Spineart

Chemin du Pré-Fleuri 3, Plan-les-Ouates, Genève 1228, CH

Spineart is a privately held medical device company focused on accelerating technology adoption and elevating the standard of spinal care. As a global market leader in spine surgery, we support spine surgeons in over 60 markets worldwide and have introduced unique technologies in the field of minimally invasive surgery, motion preservation, fusion, biologics, fracture treatments, and more. Spineart offers a comprehensive portfolio of procedural solutions and technologies that combine traceable barcoded sterile-packed implants with compact instrument sets, ultimately promoting greater safety, cost-efficiency, and compliance for hospital systems worldwide. Spineart was awarded the "Prix de l'Economie Genevoise 2022" for its contribution to technological and scientific innovations, commercial activities, job creations and ESG principles. Join us as we continue to challenge convention, deliver global expertise, and empower superior care. See open positions at https://www.spineart.com/careers/ This profile is intended for global audiences. For US-specific updates follow our Spineart USA profile.

Straumann Group

Straumann Group

Peter Merian-Weg 12, Basel, Basel-Town 4052, CH

United for global excellence in dentistry. Every vision has its story, and ours began more than 60 years ago. Since then, our innovations and achievements have become landmarks in dentistry worldwide. Straumann began as a family-owned institute, grew into a publicly-owned holding, and today comprises a number of leading and talented companies around the world. Our vision has always been to create more than just smiles, but lasting confidence for dentists, labs, patients, employees, partners, dental networks and the global community.

Xeltis

Xeltis

Zurich, Switzerland

Xeltis is developing artificial vessels and valves that are gradually replaced by patients’ own living healthy tissue. www.xeltis.com